Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Antithrombin III (ATIII)
16%
Apolipoprotein A-I (apoA-I)
16%
Apolipoprotein B (apo B)
16%
Blood Pressure
16%
C-level
16%
Cardiovascular Disease
33%
Cardiovascular Risk Factors
100%
Coronary Heart
16%
Coronary Heart Disease
33%
Current Users
83%
Epidemiologic Studies
33%
Estrogen
83%
Estrogen Alone
50%
Estrogen Replacement Therapy
33%
Fasting Blood Glucose
16%
Fasting Insulin
16%
Fibrinogen
16%
Hemostatic Factors
33%
High Density
33%
High Triglycerides
16%
High-density Lipoprotein Cholesterol (HDL-C)
16%
Hormone Replacement Therapy
100%
Insulin
16%
Lipid Factors
16%
Lipoproteins
33%
Low-density Lipoprotein Cholesterol (LDL-C)
16%
Physiologic
16%
Physiological Effects
16%
Plasma Concentration
16%
Plasma Lipids
16%
Population-based Investigation
16%
Postmenopausal Women
100%
Progestin
83%
Protective Effect
50%
Randomized Trial
16%
Selection Bias
16%
Serum Concentration
16%
United States
16%
Medicine and Dentistry
Antithrombin III
12%
Apolipoprotein A
12%
Apolipoprotein B
12%
Blood Pressure
12%
Cardiovascular Disease
25%
Cardiovascular Risk
100%
Cohort Effect
25%
Estrogen
100%
Estrogen Therapy
25%
Factor VII
12%
Fibrinogen
12%
Gestagen
62%
Glucose
37%
Hemostat
25%
High Density Lipoprotein Cholesterol
12%
Hormone Substitution
100%
Insulin
25%
Ischemic Heart Disease
25%
Lipid
12%
Lipoprotein
25%
Low Density Lipoprotein Cholesterol
12%
Observational Study
12%
Postmenopause
100%
Prospective Study
12%
Protein C
12%
Selection Bias
12%
Triacylglycerol
12%
Nursing and Health Professions
Antithrombin III
12%
Apolipoprotein A
12%
Apolipoprotein B
12%
Blood Clotting Factor 7
12%
Blood Level
12%
Blood Pressure
12%
Cardiovascular Disease
25%
Cardiovascular Risk
100%
Estrogen
100%
Estrogen Therapy
25%
Fibrinogen
12%
Gestagen
62%
Glucose
25%
Glucose Blood Level
12%
Hemostatic Agent
25%
High Density Lipoprotein Cholesterol
12%
Hormone Substitution
100%
Insulin
12%
Insulin Blood Level
12%
Ischemic Heart Disease
25%
Lipid Blood Level
12%
Lipoprotein
12%
Lipoprotein A
12%
Low Density Lipoprotein Cholesterol
12%
Protein C
12%
Triacylglycerol
12%
Pharmacology, Toxicology and Pharmaceutical Science
Antithrombin III
10%
Apolipoprotein A
10%
Apolipoprotein B
10%
Blood Clotting Factor 7
10%
Cardiovascular Disease
20%
Cardiovascular Risk
100%
Estrogen
100%
Fibrinogen
10%
Glucose
30%
Hemostatic Agent
20%
High Density Lipoprotein Cholesterol
10%
Insulin
20%
Ischemic Heart Disease
20%
Lipid
10%
Lipoprotein
10%
Lipoprotein A
10%
Low Density Lipoprotein Cholesterol
10%
Observational Study
10%
Progestin
50%
Prospective Study
10%
Protein C
10%
Replacement Therapy
100%
Triacylglycerol
10%
Neuroscience
Antithrombin III
11%
Apolipoprotein A
11%
Apolipoprotein B
11%
Blood Plasma
22%
Cardiovascular System
100%
Estrogen
100%
Estrogen Replacement Therapy
11%
Factor VII
11%
Fibrinogen
11%
Glucose
33%
High Density Lipoprotein Cholesterol
11%
Insulin
22%
Ischemic Heart Disease
22%
Lipid
11%
Low Density Lipoprotein Cholesterol
11%
Progestin
55%
Protein C
11%
Risk Factor
100%
Triacylglycerol
11%